Showing 1 - 14 results of 14 for search '"Nuclear Magnetic Resonance"', query time: 0.07s Refine Results
  1. 1
  2. 2

    Plasma nuclear magnetic resonance metabolomics discriminates between high and low endoscopic activity and predicts progression in a prospective cohort of patients with ulcerative colitis by Probert, F, Walsh, A, Jagielowicz, M, Yeo, T, Claridge, T, Simmons, A, Travis, S, Anthony, D

    Published 2018
    “…<strong>Methods</strong> Plasma nuclear magnetic resonance [NMR] spectra from 40 patients with UC followed prospectively over 6 months were analysed with multivariate statistics. …”
    Journal article
  3. 3
  4. 4

    Data for 'Aromatic and antiaromatic ring currents in a molecular nanoring' by Peeks, M, Claridge, T, Anderson, H

    Published 2016
    Subjects: “…Nuclear magnetic resonance spectroscopy…”
    Dataset
  5. 5

    Reliable, high-quality suppression of NMR signals arising from water and macromolecules: application to bio-fluid analysis by Aguilar, J, Cassani, J, Probert, F, Palace, J, Claridge, T, Botana, A, Kenwright, A

    Published 2019
    “…Analysis of metabolites in biofluids using nuclear magnetic resonance often requires the suppression of obscuring signals arising from water and macromolecules. …”
    Journal article
  6. 6

    EQUIPMENT FOR SELECTIVE EXCITATION IN NMR-SPECTROSCOPY - ENHANCED TECHNIQUES FOR RADIOFREQUENCY MODULATION AND DIGITAL PULSE-SHAPE GENERATION by Gregory, N, Claridge, T, Derome, A

    Published 1994
    “…This paper describes readily constructed electronic equipment for generating shaped pulses for use in nuclear magnetic resonance spectroscopy. A radio-frequency modulator is controlled by the analogue waveshape supplied by a digital waveform generator. …”
    Journal article
  7. 7

    Swarm formation in the desert locust Schistocerca gregaria: isolation and NMR analysis of the primary maternal gregarizing agent. by Miller, G, Islam, MS, Claridge, T, Dodgson, T, Simpson, S

    Published 2008
    “…In a final series of experiments, we characterized the most specific gregarizing fraction by nuclear magnetic resonance (NMR) spectroscopy. Here we present tentative structural features of the primary locust maternal gregarizing agent, which appears to be an alkylated l-dopa analogue. …”
    Journal article
  8. 8

    NMReDATA, a standard to report the NMR assignment and parameters of organic compounds by Pupier, M, Nuzillard, J, Wist, J, Schlörer, N, Kuhn, S, Erdelyi, M, Steinbeck, C, Williams, A, Butts, C, Claridge, T, Mikhova, B, Robien, W, Dashti, H, Eghbalnia, H, Farès, C, Adam, C, Kessler, P, Moriaud, F, Elyashberg, M, Argyropoulos, D, Pérez, M, Giraudeau, P, Gil, R, Trevorrow, P, Jeannerat, D

    Published 2018
    “…These NMR parameters, which we shall call NMReDATA (for nuclear magnetic resonance extracted data), include chemical shift values, signal integrals, intensities, multiplicities, scalar coupling constants, lists of 2D correlations, relaxation times, and diffusion rates. …”
    Journal article
  9. 9

    The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis. by Gray, E, Larkin, J, Claridge, T, Talbot, K, Sibson, N, Turner, M

    Published 2015
    “…Metabolomic analysis of cerebrospinal fluid (CSF) using proton nuclear magnetic resonance ((1)H-NMR) spectroscopy is a highly sensitive method capable of revealing nervous system cellular pathology. …”
    Journal article
  10. 10

    A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. by Dickens, A, Larkin, JR, Griffin, J, Cavey, A, Matthews, L, Turner, M, Wilcock, G, Davis, B, Claridge, T, Palace, J, Anthony, D, Sibson, N

    Published 2014
    “…OBJECTIVE: We tested whether it is possible to differentiate relapsing-remitting (RR) from secondary progressive (SP) disease stages in patients with multiple sclerosis (MS) using a combination of nuclear magnetic resonance (NMR) metabolomics and partial least squares discriminant analysis (PLS-DA) of biofluids, which makes no assumptions on the underlying mechanisms of disease. …”
    Journal article
  11. 11

    NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls. by Probert, F, Ruiz-Rodado, V, te Vruchte, D, Nicoli, E, Claridge, T, Wassif, C, Farhat, N, Porter, F, Platt, F, Grootveld, M

    Published 2017
    “…Here we employed high-resolution 1H nuclear magnetic resonance spectroscopy coupled with advanced multivariate analysis techniques in order to explore and seek differences between blood plasma samples acquired from NPC1 (untreated and miglustat treated), heterozygote, and healthy control subjects. …”
    Journal article
  12. 12

    Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites by Chan, SY, Probert, F, Radford-Smith, D, Hebert, J, Claridge, T, Anthony, D, Burnet, P

    Published 2020
    “…In a separate mouse cohort, pro-inflammatory cytokine gene expression and 1H nuclear magnetic resonance (NMR) metabolomics measurements were made in brain tissue and blood. …”
    Journal article
  13. 13

    Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease. by Jurynczyk, M, Probert, F, Yeo, T, Tackley, G, Claridge, T, Cavey, A, Woodhall, M, Arora, S, Winkler, T, Schiffer, E, Vincent, A, DeLuca, G, Sibson, N, Leite, M, Waters, P, Anthony, D, Palace, J

    Published 2017
    “…Plasma samples from 108 patients (34 RRMS, 54 AQP4-Ab NMOSD, and 20 MOG-Ab disease) were analysed by nuclear magnetic resonance spectroscopy followed by lipoprotein profiling. …”
    Journal article
  14. 14

    Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease by Jurynczyk, M, Probert, F, Yeo, T, Tackley, G, Claridge, T, Cavey, A, Woodhall, M, Arora, S, Winkler, T, Schiffer, E, Vincent, A, DeLuca, G, Sibson, N, Leite, M, Waters, P, Anthony, D, Palace, J

    Published 2017
    “…Plasma samples from 108 patients (34 RRMS, 54 AQP4-Ab NMOSD, and 20 MOG-Ab disease) were analysed by nuclear magnetic resonance spectroscopy followed by lipoprotein profiling. …”
    Journal article